Hakkında
Dr Diana Tait is a Consultant Clinical Oncologist, with specialist interest in upper gastrointestinal (GI), colorectal and breast cancers and a particular interest in GI chemoradiotherapy and the use of modern radiotherapy technologies for optimising treatment including CyberKnife and cone beam radiotherapy.
Dr Tait has been a Consultant at the Royal Marsden since 1988. She is also Clinical Governance Medical Lead (working to establish committees to audit procedures and improve communication between departments, patients and other centres), and since January 2009, has been Clinical Lead for the Colorectal Guidelines Development Group for NICE, in addition to her recent appointment as Registrar in the Faculty of Clinical Oncology at the RCR. She is also a member of the Clinical Audit Committee at the Royal College of Radiologists (RCR) and has been responsible for audit nationally since 2005.
Dr Tait is Clinical Oncology Lead on national and international GI research and collaborates on associated studies in both GI and breast cancer and is actively involved in research. She is principal investigator on a number of studies with the focus around using new radiotherapy technologies to improve patients' treatment management. She is currently principal investigator on one rectal study which is investigating the optimum time to surgery following pre-op chemoradiotherapy. A second study involves intensive follow-up for patients who want to avoid rectal surgery altogether by adopting a "watch and wait" policy.
Diseases, Medical Tests and Treatments
Stereotactic body radiotherapy (CyberKnife)
Home chemotherapy
GI chemoradiotherapy
Upper gastrointestinal
Colorectal caners
Breast cancers
Hepatobiliary cancers
Anal cancers
Dr Tait has been a Consultant at the Royal Marsden since 1988. She is also Clinical Governance Medical Lead (working to establish committees to audit procedures and improve communication between departments, patients and other centres), and since January 2009, has been Clinical Lead for the Colorectal Guidelines Development Group for NICE, in addition to her recent appointment as Registrar in the Faculty of Clinical Oncology at the RCR. She is also a member of the Clinical Audit Committee at the Royal College of Radiologists (RCR) and has been responsible for audit nationally since 2005.
Dr Tait is Clinical Oncology Lead on national and international GI research and collaborates on associated studies in both GI and breast cancer and is actively involved in research. She is principal investigator on a number of studies with the focus around using new radiotherapy technologies to improve patients' treatment management. She is currently principal investigator on one rectal study which is investigating the optimum time to surgery following pre-op chemoradiotherapy. A second study involves intensive follow-up for patients who want to avoid rectal surgery altogether by adopting a "watch and wait" policy.
Diseases, Medical Tests and Treatments
Stereotactic body radiotherapy (CyberKnife)
Home chemotherapy
GI chemoradiotherapy
Upper gastrointestinal
Colorectal caners
Breast cancers
Hepatobiliary cancers
Anal cancers
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Diana Tait
Eğitim ve öğretim
-
2006–2012 MD · Medicine and Surgery
-
2012–2016 Residency · Onkoloji
-
2016–2017 Fellowship · Subspecialty training
Kariyer ve atamalar
-
2016-09–2017-08 Junior consultant
Lisanslar ve sigorta
Tıbbi lisanslar
GB — Organización Médica Colegial de España (OMC)
Kurul sertifikaları
European Board of Onkoloji
Mesleki sorumluluk sigortası:
Allianz Professional · 5,000,000 EUR kapsam · No claims on file
Gerçekleştirilen prosedürler
| Prosedür | Kod | Toplam sayı |
|---|---|---|
| GP consultation | 99213 | 2,618 |
| Annual physical exam | 99395 | 2,596 |
| Vaccination administration | 90471 | 444 |
| Minor procedure (skin) | 17110 | 2,619 |
Hizmetler ve fiyatlandırma
| Hizmet | Süre | Yöntem | Fiyat |
|---|---|---|---|
| New patient consultation (60m) | 60 dk | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 dk | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 dk | in_clinic | 540.00 EUR |
| Minor procedure (skin) | 90 dk | in_clinic | 810.00 EUR |
Ofis, ekip ve uygulamada
Videolar
Araştırma ve yayınlar
h-endeksi: 10 · i10: 10
-
European registry analysis of Onkoloji outcomes
DOI: 10.2187/euroclin.2025.0 · PMID: 32152438 · alıntılayan 106
-
Outcomes of Onkoloji in adults — a multi-centre cohort
DOI: 10.6569/euroclin.2024.1 · PMID: 36666690 · alıntılayan 144
-
European registry analysis of Onkoloji outcomes
DOI: 10.3073/euroclin.2023.2 · PMID: 37225345 · alıntılayan 126
-
Outcomes of Onkoloji in adults — a multi-centre cohort
DOI: 10.5664/euroclin.2022.3 · PMID: 39271454 · alıntılayan 4
Davetli konuşmalar
- Practical updates in Onkoloji European Annual Congress (Onkoloji) · Vienna · 2024 · invited
- Single-centre experience in Onkoloji National Society Meeting · London · 2023 · oral abstract
Ödüller ve üyelikler
Ödüller
- 🏆 Top-rated Onkoloji — London · EuroClinics Patient Choice · 2025 · regional
Topluluk üyelikleri
- WONCA Europe — Family Doctors — Member · 2017 yılından beri
- national college of family doctors — Member · 2017 yılından beri
- European Union of Medical Specialists (UEMS) — Member · 2017 yılından beri
Bu doktorun makaleleri
- Patient education Patient guide to Onkoloji
- Awareness When should you see a onkoloji?
Uluslararası hastalar için
- Koordinatör
- Patient liaison · dr.diana.tait@euroclinics.example
Konum
1 etiketHasta yorumları
Deneyiminizi paylaşın — diğer hastaların doğru doktoru bulmasına yardımcı olun. Yorum yaz →
Son yorumlar
-
★★★★★ ✓ Doğrulanmış Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Doğrulanmış Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Doğrulanmış Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
